Ad
Thursday, 5 April 2018
Hopes rise for Shire sale as Takeda CEO discusses case for deal
LONDON (Reuters) - Expectations that Takeda Pharmaceutical will bid for London-listed rare disease specialist Shire before an April 25 deadline rose on Thursday after comments from the head of the Japanese drugmaker on the merits of a deal.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment